Black Rock Inc. Genocea Biosciences, Inc. Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.01 - $1.38 $1,803 - $248,906	-180,367 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$0.96 - $1.35 $4,872 - $6,852	-5,076 Reduced 2.74%	180,367 $225,000
Q4 2021 Feb 10, 2022	BUY	$0.95 - $1.99 $4,229 - $8,859	4,452 Added 2.46%	185,443 $215,000
Q3 2021 Nov 09, 2021	BUY	$1.74 - $2.33 $3,513 - $4,704	2,019 Added 1.13%	180,991 $347,000
Q2 2021 Aug 11, 2021	BUY	$2.06 - $2.82 $368,682 - $504,701	178,972 New	178,972 $419,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.